American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting

Author:

Winer Eric P.1,Hudis Clifford1,Burstein Harold J.1,Bryant John1,Chlebowski Rowan T.1,Ingle James N.1,Edge Stephen B.1,Mamounas Eleftherios P.1,Gelber Richard1,Gralow Julie1,Goldstein Lori J.1,Pritchard Kathleen I.1,Braun Susan1,Cobleigh Melody A.1,Langer Amy S.1,Perotti Judy1,Powles Trevor J.1,Whelan Timothy J.1,Browman George P.1

Affiliation:

1. From the American Society of Clinical Oncology, Alexandria, VA.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Reference10 articles.

1. Baum M, on behalf of the ATAC Trialists’ Group: The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in post-menopausal women. Breast Cancer Res Treat 69:210,2001, (abstr 8)

2. American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002

3. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

4. New Generation Aromatase Inhibitors – from the Advanced to the Adjuvant Setting

5. Duffy SR, Jackson TL, on behalf of the ATAC Trialists’ Group: The ATAC early breast cancer trial in postmenopausal patients: Endometrial sub-protocol results. Proc Am Soc Clin Oncol 21:40a,2002, (abstr 158)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3